ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: Evidence for enhanced interactions with the insulin-like growth factor-I receptor

Molecular Carcinogenesis

Volumn 18, Issue 1, 1997, Pages 19-25

  Milazzo, Giovanni ^a,c   Sciacca, Laura ^a   Papa, Vincenzo ^a   Goldfine, Ira D ^b   Vigneri, Riccardo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Societa Indust Formaceutica I   (Italy)

Author keywords

cancer; oncogene; proliferation; transformation; tyrosine kinase

Indexed keywords

INSULIN; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR; DRUG DERIVATIVE; INSULIN RECEPTOR; INSULIN, ASP(B10); INSULIN, ASP(B10)-; MITOGENIC AGENT;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOGENESIS; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; BINDING COMPETITION; BREAST; CELL CULTURE; CELL DIVISION; CELL LINE; CHEMICALLY INDUCED DISORDER; CONTACT INHIBITION; CYTOLOGY; DRUG EFFECT; EPITHELIUM; METABOLISM; PHOSPHORYLATION;

BINDING, COMPETITIVE; BREAST; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CONTACT INHIBITION; EPITHELIUM; HUMANS; INSULIN; MITOGENS; PHENOTYPE; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; TUMOR CELLS, CULTURED;

EID: 0030614323     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M     Document Type: Article

References (28)

1. Furnaletto RW, Di Carlo JN. Somatomedin C receptors and growth effects in human breast cancer cells maintained in long term tissue culture. Cancer Res 44:2122-2128, 1984.
2. Stewart AJ, Johnson MD, May FEB, Westley BR. Role of insulin-like growth factors and type 1 insulin-like growth factor receptor in estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178, 1990.
3. Singer C, Rasmussen A, Smith HS, et al. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: Evidence for paracrine function. Cancer Res 55:2448-2454, 1995.
4. Osborne CK, Bolan G, Monaco ME, Lippman ME. Hormone responsive human breast cancer in long-term tissue culture: Effect of insulin. Proc Natl Acad Sci USA 73:4536-4540, 1976.
5. Osborne CK, Monaco ME, Lippman ME, Kahn CR. Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long-term tissue culture. Cancer Res 38:94-101, 1978.
6. Ullrich A, Bell JR, Chen EY, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-761, 1985.
7. Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512, 1986.
8. Milazzo G, Giorgino F, Damante G, et al. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52:3924-3930, 1992.
9. Papa V, Pezzino V, Costantino A, et al. Elevated insulin receptor content in human breast cancer. J Clin Invest 85:1503-1510, 1990.
10. Frittitta L, Vigneri R, Stampfer MR, Goldfine ID. Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand-dependent transformed phenotype. J Cell Biochem 57:666-669, 1995.
11. Dideriksen LH, Jørgensen LN, Drejer K. Carcinogenic effect on female rats after 12 months administration of the insulin analogue B10 ASP. Abstract. Diabetes 41:143A, 1992.
12. Drejer K. The bioactivity of insulin analogs from in vitro receptor binding to in vivo glucose uptake. Diabetes Met Rev 8:259-286, 1992.
13. Kull FC, Jacobs S, Su YF, Svoboda ME, Van Wyk JJ, Cuatrecasas P. Monoclonal antibodies to receptors for insulin and somatomedin C. J Biol Chem 258:6561-6566, 1983.
14. Soule HD, Maloney TM, Wolman SR, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086, 1990.
15. Van Wyk JJ, Graves DC, Casella SJ, Jacobs S. Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor. J Clin Endocrinol Metab 61:639-643, 1985.
16. Pezzino V, Milazzo G, Frittitta L, et al. Radioimmunoassay for human insulin-like growth factor-I: Applicability to breast carcinoma specimens and cell lines. Metabolism 40:861-865, 1991.
17. Milazzo G, Yip CC, Maddux BA, Vigneri R, Goldfine ID. High affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells. J Clin Invest 89:899-908, 1992.
18. Hagino H, Shii K, Yokono K, et al. Enzyme-linked immuno-absorbent assay method for human autophosphorylated insulin receptor. Diabetes 43:274-280, 1994.
19. Forsayeth JR, Montemurro A, Maddux BA, De Pirro R, Goldfine ID. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity and down regulation. J Biol Chem 262:4134-4140, 1987.
20. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352, 1980.
21. Duronio V, Jacobs S. Comparison of insulin and IGF-I receptors. In: Venter CJ, Harrison LC (eds), Receptor Biochemistry and Methodology, Vol 12B. Alan R. Liss, New York, 1988, pp. 3-18.
22. Drejer K, Kruse V, Larsen UD, Hougaard P, Bjorn S, Gammelofts F. Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatome HepG2 cells. Diabetes 40:1488-1495, 1991.
23. Baserga R. The insulin-like growth factor I receptor: A key to tumor growth? Cancer Res 55:249-252, 1995.
24. Prager D, Li HL, Asa S, Melmed S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91:2181-2185, 1994.
25. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 54:2212-2218, 1994.
26. Shapiro D, Jones B, Shapiro LH, Dias P, Houghton PJ. Antisense-mediated reduction in insulin-like growth factor I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest 94:1235-1242, 1994.
27. Sell C, Dumenil G, Deveaud C, et al. Effect of a null mutation of the insulin-like growth factor I gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612, 1994.
28. Hansen BF, Danielsen G, Drejer K, et al. Sustained signaling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J 351:271-279, 1996.